|
Safety and Tolerability Study of FPTI in Combination with Docetaxel in Advanced Solid Tumors Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for certified healthcare advice, travels to or professional assistance using a genuine medical doctor. We are not physicians. Always confer with your dr. about Safety and Tolerability Study of FPTI in Combination with Docetaxel in Advanced Solid Tumors conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Safety and Tolerability Study of FPTI in Combination with Docetaxel in Advanced Solid Tumors Clinical research trials and Safety and Tolerability Study of FPTI in Combination with Docetaxel in Advanced Solid Tumors medical trials happen in hundreds of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectualness of new drugs. The intention of the studies / undertakings is to solve certain human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all forms of circumstances, such as Safety and Tolerability Study of FPTI in Combination with Docetaxel in Advanced Solid Tumors. Safety and Tolerability Study of FPTI in Combination with Docetaxel in Advanced Solid Tumors Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the general public. Some times the human subjects get treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Safety and Tolerability Study of FPTI in Combination with Docetaxel in Advanced Solid Tumors clinical trial. Participants frequently get the best healthcare available for their Safety and Tolerability Study of FPTI in Combination with Docetaxel in Advanced Solid Tumors condition. Risks are a reality, nonetheless, and can include extra or frequent physician trips, medical risks (possibly life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Safety and Tolerability Study of FPTI in Combination with Docetaxel in Advanced Solid Tumors  Safety and Tolerability Study of FPTI in Combination with Docetaxel in Advanced Solid Tumors
Safety and Tolerability Study of FPTI in Combination with Docetaxel in Advanced Solid Tumors
For Condition: Neoplasms
Status: No longer recruiting
Sponsor(s): Schering-Plough ,
Synopsis: The purpose of this study is to determine the safety and tolerability of an oral Farnesyl Protein Transferase Inhibitor (SCH 66336) when given in combination with intravenous docetaxel in cancer patients with advanced solid tumors
Details:
Eligibility:
Study Type: Interventional, Treatment, Non-Randomized, Open Label, Dose Comparison, Parallel Assignment, Safety Study
Minimum Age/Maximum Age: 18 Years/65 Years
Genders: Both
Protocol Entry Criteria: Inclusion: - Male or Female - Measurable or evaluable disease - No more than 2 prior chemotherapy regimens. - Age greater than or equal to 18. - Karnofsky Performance Status greater than or equal to 70%. - Meets protocol requirements for specified laboratory values. - No manifestations of a malabsorption syndrome. - Written informed consent and cooperation of patient - Appropriate use of effective contraception if of child-bearing potential. Exclusion: - Acute or chronic leukemia or multiple myeloma. - Evidence of 2 or more active malignancies, expect for in situ or adequately treated basal or squamous cell skin cancer.
Total Enrollment: 24
Location and Contact Information:
M.D. Anderson Cancer Center-Fadio Khuri, MD
Houston, Texas,
United States
Duke University
Raleigh, North Carolina,
United States
University Health Network-Princess Margaret Hospital
Toronto, ,
Canada
University of Texas
Houston, Texas,
United States
University of Texas
Houston, Texas,
United States
University of Texas
Houston, Texas,
United States
Cornell University Medical College
New York City, New York,
United States
Additional Information:
Study ID Numbers: P01964;
Study Start Date: June 2001
Record last reviewed: March 2001
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00040547
Other Neoplasms Studies:
1. Radiation Therapy and the Natural History of Childhood Cancers
2. Phase I Study of Anakinra to Treat Advanced Cancers that Produce Interluekin-1
3. Phase I Study of Noni in Cancer Patients
4. Harvesting Cells for Experimental Cancer Treatments
5. ALIMTA (pemetrexed) and Gemcitabine (gemzar) in Patients with Advanced Cancer
Related Studies:
Other Neoplasms Clinical Trials
Other New York Clinical Trials
Other New York City Clinical Trials
Safety and Tolerability Study of FPTI in Combination with Docetaxel in Advanced Solid Tumors
|
|
|
|
|
|
|
|
